...
首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >Autophagy represses fascaplysin-induced apoptosis and angiogenesis inhibition via ROS and p8 in vascular endothelia cells
【24h】

Autophagy represses fascaplysin-induced apoptosis and angiogenesis inhibition via ROS and p8 in vascular endothelia cells

机译:通过ROS和P8在血管内皮细胞中抑制Fascaplysin诱导的细胞凋亡和血管生成抑制

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Fascaplysin is a natural product isolated from marine sponges that exhibits broad anticancer activity. Previous studies revealed that fascaplysin-induced apoptosis and angiogenesis inhibition in vascular endothelial cells contributed to its anticancer activity. Accumulating evidence indicates that autophagy plays a significant role in mediating the function of vascular endothelial cells (VECs) and the response to cancer therapy. However, the effect of fascaplysin on VEC autophagy and the role of autophagy in fascaplysin-induced vascular endothelial cell apoptosis and angiogenesis inhibition are not clear. The present study found that fascaplysin induced autophagy in vascular endothelial cells. Suppression of autophagy using a pharmacological inhibitor (3-methyladenine) or RNA interference of an essential autophagy gene (ATG5) enhanced the cell death and anti-angiogenesis activity of fascaplysin. We further found that fascaplysin significantly increased p8 protein and reactive oxygen species (ROS) levels and decreased mitochondrial membrane potential but had no effect on the mTOR pathway in VECs. Notably, the ROS scavenger N-acetylcysteine inhibited fascaplysin-induced autophagy and increased p8 protein level. Knockdown of p8 by using RNA interference inhibited the autophagy but increased the level of ROS in VECs. Taken together, these data indicated that fascaplysin activated autophagy as a cytoprotective response via ROS and p8 in VECs. Our findings provided important insight into the response of VECs to fascaplysin and may be useful for improving the anticancer efficacy of fascaplysin.
机译:Fascaplysin是一种自然产品,从野外海绵中分离出来,展示广泛的抗癌活动。以前的研究表明,血管内皮细胞中的Fascaplysin诱导的凋亡和血管生成抑制有助于其抗癌活性。积累证据表明自噬在介导血管内皮细胞(VECS)的功能和对癌症治疗的反应中起着重要作用。然而,Fascaplysin对VEC自噬的影响和自噬在Fascaplysin诱导的血管内皮细胞凋亡和血管生成抑制中的作用尚不清楚。本研究发现,Fascaplysin诱导血管内皮细胞的自噬。使用药理学抑制剂(3-甲基腺嘌呤)或基因的RNA干扰抑制自噬(ATG5)增强了Fascaplysin的细胞死亡和抗血管生成活性。我们进一步发现,Fascaplysin显着增加P8蛋白和反应性氧物质(ROS)水平,并且线粒体膜电位降低,但对VEC的MTOR途径没有影响。值得注意的是,ROS清除剂N-乙酰半胱氨酸抑制了Fascaplysin诱导的自噬和增加的P8蛋白质水平。通过使用RNA干扰敲低P8抑制自噬,但增加了VEC中的ROS水平。总之,这些数据表明,Fascaplysin通过ROS和P8在VEC中激活自噬作为细胞保护反应。我们的调查结果为VECS对Fascaplysin的反应提供了重要的了解,可用于改善Fascaplysin的抗癌疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号